首页|口服普瑞巴林对胸腔镜手术患者术后睡眠的影响

口服普瑞巴林对胸腔镜手术患者术后睡眠的影响

扫码查看
目的 观察术后口服普瑞巴林对电视辅助胸腔镜手术(VATS)患者术后睡眠的影响。方法 择期全麻下行VATS的患者120例,随机分为75 mg普瑞巴林组(A组)、150 mg普瑞巴林组(B组)和安慰剂组(C组),每组40例。于手术当晚、术后第1天和第2天早晚,3组患者分别口服普瑞巴林1粒和形状气味相同的安慰剂1粒、普瑞巴林2粒以及安慰剂2粒。手术当晚采用雅典失眠量表(AIS)评估患者术后睡眠障碍(PSD)发生率,采用St。Mary's医院睡眠问卷(SMH)评估患者术前至术后第2天的每夜睡眠质量,术前1 d、术后7 d和1个月,采用匹兹堡睡眠质量指数(PSQI)评估患者术前和术后的睡眠情况,采用数字疼痛评分(NRS)评估患者术后切口和肩部疼痛;记录补救镇痛情况、术后72 h内不良反应的发生情况以及患者满意度评分。结果 A、B、C组患者PSD发生率分别为45。0%,42。5%,72。5%;A组、B组均明显低于C组(分别与C组两两比较,P<0。016 7)。术后3d,A组、B组SMH评分明显高于C组(分别与C组两两比较,P<0。016 7)。术后第1、第2天,A、B两组切口处NRS评分和术后补救镇痛发生率显著低于C组(分别与C组两两比较,P<0。016 7);其余时间点,3组患者切口处和肩部疼痛评分差异无统计学意义(P>0。05)。A组、B组术后患者满意度评分明显高于C组(P<0。01)。B组头晕发生率明显高于A、C两组(P<0。016 7)。结论 VATS术后连续3d 口服普瑞巴林可降低患者PSD发生率,改善睡眠质量,但150 mg普瑞巴林可能增加头晕发生率。
Effect of oral pregabalin on postoperative sleep of patients undergoing video-assisted thoracoscopic surgery
Objective To explore the effect of pregabalin on sleep of patients after video-assisted thoracic surgery(VATS).Methods 120 cases of patients undergoing VATS under general anesthesia were randomly divided into 75 mg pregabalin group(group A),150 mg pregabalin group(group B),and placebo group(group C),with 40 patients in each group.On the night of the operation,the morning and evening of the first day and the second day after the operation,the patients in the three groups were given one tablet of pregabalin(75 mg),one tablet of placebo with the same shape and smell,two tablets of pregabalin(150 mg)and two tablets of placebo with the same shape and smell respectively.Athens insomnia scale(AIS)was used to evaluate the incidence of postoperative sleep disturbance(PSD)on the night of operation,and the patients'sleep quality every night from one night before operation to the 2nd day after operation was assessed using the St.Mary's Hospital sleep questionaire(SMH).Pittsburgh sleep quality index(PSQI)was used to evaluate the patients'sleep quality one day before the operation,7 days after operation,and 1 month after the operation.The digital rating scale(NRS)was used to evaluate the patients'pain at the incision and the surgical side.The remedial analgesia,incidence of adverse events in the 72 h postoperative period,and patient satisfaction score were recorded.Results The incidence of PSD in group A,group B and group C was 45.0%,42.5%and 72.5%,respectively,the incidence of group A and group B was significantly lower than in group C(group A,B and C compared in pairs,P<0.016 7).The SMH scores in group A and group B were significantly higher than in group C on the day of operation,the first day and the second day after operation(group A,B and C compared in pairs,P<0.016 7).The incidence of NRS scores in groups A and B at the incision and postoperative remedial analgesia was significantly lower than in group C on postoperative day 1 and postoperative day 2(group A,B and C compared in pairs,P<0.016 7).There was no statistically significant difference in the pain scores at the incision and shoulder among the three groups at the remaining time points.The postoperative patient satisfaction scores were significantly higher in group A and group B than in group C(P<0.01).The incidence of dizziness in group B was significantly higher than in the other two groups(P<0.016 7).Conclusion Oral administration of pregabalin(75 mg/150 mg)for 3 days after VATS can reduce the incidence of PSD and improve the quality of sleep that night,but oral administration of 150 mg pregabalin may increase the incidence of dizziness.

PregbalinPostoperative sleep disturbanceVideo-assisted thoracic surgeryLung cancer

刘泓妍、王清峰、刘郁鋆、张丽、徐衹彪、赵林林

展开 >

徐州医科大学麻醉学院(江苏徐州 221004)

徐州医科大学附属医院麻醉科(江苏徐州 221002)

普瑞巴林 术后睡眠障碍 胸腔镜手术 肺癌

2024

药物流行病学杂志
中国药学会 武汉医药(集团)股份有限公司

药物流行病学杂志

CSTPCD
影响因子:0.746
ISSN:1005-0698
年,卷(期):2024.33(5)